Buffalo's investment in a medical research future earned a dividend recently. Roswell Park Cancer Institute has lured a high-level cancer scientist and his company from none other than the Cleveland Clinic.
The deal was reached through five months of collective negotiating efforts involving stakeholders at various levels in both business and government, including the governor's office and State Legislature. Noted researcher Andrei V. Gudkov will bring to Buffalo the publicly traded biotechnology company he founded, Cleveland BioLabs, along with nearly three dozen well-paying jobs.
Ultimately, officials have indicated, the deal could bring up to 50 jobs to this area, including the initial 20 to 30 from the company plus an additional 15 to 20 scientists and technicians for Gudkov's personal lab at Roswell Park. These high-profile positions, paying an average salary of about $80,000, will affect the local economy and could act as a catalyst for others in the continuing effort to expand and develop the Buffalo Niagara Medical Campus.
Gudkov's presence will further enhance Roswell Park Cancer Institute's solid reputation, as well. All those who negotiated this deal deserve credit, and we hope the relocation will be just as positive a move for Gudkov and his company as it promises to be for Buffalo.